NPPES file of Aug 9, 2026

Sharifa Alhassan

Endocrinology, Diabetes & Metabolism Physician · Wyomissing, PA

Sharifa Alhassan is an endocrinology, diabetes & metabolism physician with a practice address in Wyomissing, Pennsylvania, and NPI 1902240468, issued on Apr 26, 2013. Check the license on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1902240468
Name
Sharifa Alhassan
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
29104 WV
Self-reported in NPPES; status is on the state search
Practice location
1991 State Hill RD, Wyomissing, PA 19610
Phone
(484) 628-4270
Enumerated
Apr 26, 2013
Record last updated
Apr 19, 2023
Fax
(484) 628-4261
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1991 State Hill RD

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Scott Benkovic, DOPhysical Medicine & Rehabilitation Physician1497216147
  2. Sarah Clair, R.D.Registered Dietitian1174653679
  3. Karen Franey, R.D.Registered Dietitian1881724383
  4. Ilan Gabriely, MDEndocrinology, Diabetes & Metabolism Physician1306927728
  5. Megan Gallagher, RDRegistered Dietitian1285141390
  6. James Leu, M.D.Endocrinology, Diabetes & Metabolism Physician1841453677

Verify Sharifa Alhassan in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersPennsylvania Department of State (PALS)Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Pennsylvania license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

69% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

817 Medicare Part D claims for 179 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 42% of claims.

  1. Sharifa Alhassan817
  2. Specialty average2,630

Most prescribed

  1. Levothyroxine Sodium161 claims
  2. Methimazole116 claims
  3. Ozempic51 claims
  4. Hydrocortisone39 claims
  5. Lantus Solostar37 claims
  6. Metformin Hcl37 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Sharifa Alhassan among 485 endocrinology, diabetes & metabolism physician records in Pennsylvania

Sharifa Alhassan is one of 485 endocrinology, diabetes & metabolism physician records with a practice address in Pennsylvania. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2013, is newer than 74% of them.

  • NPI issued2013 · 74% of these records are older, 24% newer
  • In a Medicare fileYes · 84% of these records are
  • In the CMS Doctors and Clinicians fileNo · 69% of these records are
  • Record last updated2023 · 62% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in Pennsylvania

There are 485 endocrinology, diabetes & metabolism physician records in Pennsylvania.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Ravisha Bai, MDReading, PA 196101598162265
  2. David Deibert, M.D.Wyomissing, PA 196101528119955
  3. Ilan Gabriely, MDWyomissing, PA 196101306927728
  4. James Leu, M.D.Wyomissing, PA 196101841453677
  5. Chheki Sherpa, M.D.Wyomissing, PA 196101093070765
  6. Vinita Singh, M.D.Wyomissing, PA 196101790037836
  7. Sheldon Schlaff, M.D.West Reading, PA 196111073779393
  8. David Lawrence, M.D.Wernersville, PA 195651538195441

Common questions

What is Sharifa Alhassan's NPI number?

Sharifa Alhassan's National Provider Identifier (NPI) is 1902240468, issued on Apr 26, 2013. An NPI identifies a provider in billing; it is not a license.

Where is Sharifa Alhassan located?

The NPPES record lists a practice address at 1991 State Hill RD, Wyomissing, PA, 19610. Phone: (484) 628-4270. Providers update this record themselves, so call before visiting.

How can I verify Sharifa Alhassan's license?

Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Sharifa Alhassan prescribe under Medicare Part D?

In 2024, Sharifa Alhassan had 817 Medicare Part D claims for 179 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.